JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$232.12
+1.04%Forward multiples
Based on analyst estimates
- P/E forward
- 8.81x
- P/E 2026E
- 15.23x
- P/E 2027E
- 8.59x
- P/E 2028E
- 8.40x
- P/S forward
- 2.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- 64.84x
- PEG TTM
- 0.10x
- Price / book
- 3.55x
- Price / sales
- 3.16x
- Price / cash flow
- 8.80x
Enterprise value
- Enterprise value
- $17.7B
- EV / sales
- 3.75x
- EV / EBITDA
- 15.13x
- EV / EBIT
- 18.47x
- Market cap
- $14.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026